SVP and CFO Thomas R Staab II sold $75K of BioCryst Pharmaceuticals, Inc.

Sold$74,595

$7.65Price

9,750Shares

−7%Stake

What BCRX did after the filing

Prices for BCRX after this filing aren't in yet.

Traded Thu, May 16. Filed Mon, May 20, 4:21 PM ET, after the close. Not investment advice.